Cargando…
AR-Signaling in Human Malignancies: Prostate Cancer and Beyond
In the 1940s Charles Huggins reported remarkable palliative benefits following surgical castration in men with advanced prostate cancer, and since then the androgen receptor (AR) has remained the main therapeutic target in this disease. Over the past couple of decades, our understanding of AR-signal...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5295778/ https://www.ncbi.nlm.nih.gov/pubmed/28085048 http://dx.doi.org/10.3390/cancers9010007 |